Resmed Inc Stock Alpha and Beta Analysis
| RMD Stock | USD 224.16 4.44 2.02% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as ResMed Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in ResMed over a specified time horizon. Remember, high ResMed's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ResMed's market risk premium analysis include:
Beta 0.48 | Alpha (0.05) | Risk 2.02 | Sharpe Ratio (0.06) | Expected Return (0.13) |
ResMed Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
ResMed |
ResMed Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ResMed market risk premium is the additional return an investor will receive from holding ResMed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ResMed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ResMed's performance over market.| α | -0.05 | β | 0.48 |
ResMed expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of ResMed's Buy-and-hold return. Our buy-and-hold chart shows how ResMed performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.ResMed Market Price Analysis
Market price analysis indicators help investors to evaluate how ResMed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ResMed shares will generate the highest return on investment. By understating and applying ResMed stock market price indicators, traders can identify ResMed position entry and exit signals to maximize returns.
ResMed Return and Market Media
The median price of ResMed for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 235.65 with a coefficient of variation of 3.22. The daily time series for the period is distributed with a sample standard deviation of 7.61, arithmetic mean of 236.17, and mean deviation of 5.79. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | MASI Stock Gains Following Q4 Earnings Beat, Gross Margin Contracts | 02/26/2025 |
2 | Disposition of tradable shares by Michael Rider of ResMed at 234.1 subject to Rule 16b-3 | 03/03/2025 |
3 | SP 500 Gains and Losses Today Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine Optimism | 03/05/2025 |
4 | Medical conference to raise awareness on sleep health | 03/06/2025 |
5 | Insider Sell Alert Peter Farrell Sells 2,000 Shares of ResMed Inc | 03/07/2025 |
6 | ResMed Inc Trading 4.49 percent Higher on Mar 10 | 03/10/2025 |
7 | Resmed unveils unified brand to streamline services | 03/11/2025 |
8 | RMD and XRO shares why you should take notice | 03/12/2025 |
About ResMed Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ResMed or other stocks. Alpha measures the amount that position in ResMed Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.008054 | 0.0103 | 0.0118 | 0.0138 | Price To Sales Ratio | 7.59 | 5.87 | 5.28 | 4.26 |
ResMed Upcoming Company Events
As portrayed in its financial statements, the presentation of ResMed's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ResMed's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of ResMed's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of ResMed. Please utilize our Beneish M Score to check the likelihood of ResMed's management manipulating its earnings.
| 25th of April 2024 Upcoming Quarterly Report | View | |
| 1st of August 2024 Next Financial Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View | |
| 1st of August 2024 Next Fiscal Year End | View | |
| 31st of December 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
Build Portfolio with ResMed
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out ResMed Backtesting, ResMed Valuation, ResMed Correlation, ResMed Hype Analysis, ResMed Volatility, ResMed History and analyze ResMed Performance. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
ResMed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.